ArticleInternational journal of general medicine2026
Comprehensive Analysis of the Relationship Between Cardiometabolic Index and Coronary Heart Disease.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Emerging evidence substantiates the cardiometabolic index (CMI) as a pivotal indicator demonstrating robust associations with an array of cardiovascular pathologies. However, its specific link to coronary heart disease (CHD) remains insufficiently explored. This study aimed to investigate both the association and the predictive value of CMI for CHD in a clinical cohort. Methods: This retrospective study included patients with suspected CHD who underwent coronary angiography at the Cardiology Department of Chengde Central Hospital between October 2023 and December 2024. Participants were stratified into CHD and non-CHD groups based on angiographic results. A LASSO regression and a logistic regression framework was implemented to examine the influence of age, sex, hypertension, diabetes, smoking, WBC, CK, CMI, and LDL-C on CHD. The association between CMI and CHD was explored using restricted cubic spline (RCS) methodology. The diagnostic efficacy of the model was scrutinized through the utilization of the area under the curve (AUC). Results: CMI exhibits an independent predictor for CHD, particularly in individuals with high CMI values (Q4 group), where the risk of CHD is markedly elevated. Furthermore, a linear relationship exists between CMI and CHD. Calibration curves demonstrate a strong alignment correlation linking predicted to observed probabilities. Decision curve analysis (DCA) reveals that the model provides substantial clinical benefit within a threshold probability range of 0.13 to 0.72. Receiver operating characteristic (ROC) curve analysis indicates that CMI possesses certain predictive merit for the occurrence of CHD. Conclusion: A positive association exists between CMI and incidence of CHD. Additionally, CMI serves as an independent risk factor, demonstrating certain predictive power in clinical settings, thereby effectively forecasting the risk of CHD occurrence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.